Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection

Peter A. McCullough, John Eidt, Janani Rangaswami, Edgar Lerma, James Tumlin, Kevin Wheelan, Nevin Katz, Norman E. Lepor, Kris Vijay, Sandeep Soman, Bhupinder Singh, Sean P. McCullough, Haley B. McCullough, Alberto Palazzuoli, Gaetano M. Ruocco, Claudio Ronco

Rev. Cardiovasc. Med. 2020, 21(1), 1–7; https://doi.org/10.31083/j.rcm.2020.01.42

Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians

Federico Ronco, Giuseppe Tarantini, Peter A. McCullough

Rev. Cardiovasc. Med. 2020, 21(1), 9–23; https://doi.org/10.31083/j.rcm.2020.01.44

The dynamic relationship between serum chloride and cardiorenal syndrome

Amir Kazory, Maria Rosa Costanzo

Rev. Cardiovasc. Med. 2020, 21(1), 25–29; https://doi.org/10.31083/j.rcm.2020.01.6

(This article belongs to the Special Issue Cardiovascular disorders in chronic kidney disease)

Management of heart failure in patients with end-stage kidney disease on maintenance dialysis: a practical guide

Megan S. Joseph, Maryse Palardy, Nicole M. Bhave

Rev. Cardiovasc. Med. 2020, 21(1), 31–39; https://doi.org/10.31083/j.rcm.2020.01.24

(This article belongs to the Special Issue Cardiovascular disorders in chronic kidney disease)

Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration

María M. Adeva-Andany, Carlos Fernández-Fernández, Natalia Carneiro-Freire, Elvira Castro-Quintela, Ana Pedre-Piñeiro, Mónica Seco-Filgueira

Rev. Cardiovasc. Med. 2020, 21(1), 41–56; https://doi.org/10.31083/j.rcm.2020.01.5102

(This article belongs to the Special Issue Cardiovascular disorders in chronic kidney disease)

Potential roles of microRNA-1 and microRNA-133 in cardiovascular disease

Zhipeng Song, Rui Gao, Bo Yan

Rev. Cardiovasc. Med. 2020, 21(1), 57–64; https://doi.org/10.31083/j.rcm.2020.01.577

Coronary artery bypass graft surgery versus percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review

Liviu Macovei, Robert Magopet, Ana Tanasa, Cezara Raileanu, Cristina Prisacariu, Mihai Razvan Presura, Mircea Ovanez Balasanian

Rev. Cardiovasc. Med. 2020, 21(1), 65–73; https://doi.org/10.31083/j.rcm.2020.01.590

Endovascular and open surgical repair of abdominal aortic aneurysms: A comparative analysis of western and chinese studies

Feng Shi, Yuchen He, Shiyue Wang, Fuqiang Jia, Chao Ji, Jian Zhang, Xun Liu, Yanshuo Han

Rev. Cardiovasc. Med. 2020, 21(1), 75–92; https://doi.org/10.31083/j.rcm.2020.01.513

Imaging with intracardiac echocardiography compared to transesophageal echocardiography during left atrial appendage occlusion

Guicheng Liang, Beizhu Xu, Shirong Wang, Chengxuan Li, Guoqiang Zhong

Rev. Cardiovasc. Med. 2020, 21(1), 93–101; https://doi.org/10.31083/j.rcm.2020.01.569

Effect of remote ischemic preconditioning in patients with STEMI during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials

En Chen, Wei Cai, Danqing Hu, Lianglong Chen

Rev. Cardiovasc. Med. 2020, 21(1), 103–112; https://doi.org/10.31083/j.rcm.2020.01.10

LCZ696 and preservation of renal function in heart failure: A meta-analysis of 6 randomized trials

Xiaogen Chen, Chunna Jin, Lan Xie, Meixiang Xiang

Rev. Cardiovasc. Med. 2020, 21(1), 113–118; https://doi.org/10.31083/j.rcm.2020.01.2

Imminent rupture of abdominal aortic aneurysm complicated by arteriovenous fistulaization and hepatorenal failure: case report and literature review

Daozheng Huang, Feier Song, Xiaomin Zhou, Huan Ma, Shuo Chen, Yinjun Xie, Shouhong Wang, Tiehe Qin

Rev. Cardiovasc. Med. 2020, 21(1), 119–122; https://doi.org/10.31083/j.rcm.2020.01.588

Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study

Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami

Rev. Cardiovasc. Med. 2020, 21(1), 123–127; https://doi.org/10.31083/j.rcm.2020.01.552

Complete Entry and Re-entry Neutralization protocol in endovascular treatment of aortic dissection

Tomasz Jędrzejczak, Paweł Rynio, Rabih Samad, Anita Rybicka, Agata Krajewska, Piotr Gutowski, Arkadiusz Kazimierczak

Rev. Cardiovasc. Med. 2020, 21(1), 129–137; https://doi.org/10.31083/j.rcm.2020.01.5105

Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention

Ya Wang, Wen-Jing Sun, Ze-Sheng Ji, Chong-Bin Liu, Rui Wang

Rev. Cardiovasc. Med. 2020, 21(1), 139–145; https://doi.org/10.31083/j.rcm.2020.01.583

Impact of lipoprotein(a) on long-term outcomes after percutaneous coronary intervention in patients with reduced low-density lipoprotein cholesterol

Yuhong Liu, Zhihuan Zeng, Xing Yu, Tudi Li, Yusi Yao, Rong Chen, Jianyi Zheng

Rev. Cardiovasc. Med. 2020, 21(1), 147–153; https://doi.org/10.31083/j.rcm.2020.01.5101